Company Information
- Type:
- SME
- Country:
- Denmark
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 08 November 2022 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Parent Company
| Country | Company Name |
|---|---|
| Japan | Astellas Pharma Inc. |
Parent Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 25-Jul-2024 | 2024 Communication on Progress | Submitted |
| 28-Feb-2024 | 2023 Communication on Progress | Submitted |
| 29-Nov-2022 | Communication on Progress, 2022 | Active |
| 29-Nov-2022 | Communication on Progress 2022 | Active |
| 01-Dec-2021 | Annual Report 2021 for Communication on Progress | Active |
| 09-Dec-2020 | Annual Report 2020 for Communication on Progress | Active |
| 08-Jan-2020 | Annual Report 2019 for Communication on Progress | Active |
| 18-Sep-2019 | Grace Letter | Not applicable |
| 12-Oct-2018 | Communication on Progress | Active |
| 13-Oct-2017 | Annual Report 2017 for Communication on Progress Details | Active |
| 14-Oct-2016 | Annual Report 2016 for Communication on Progress | Active |
| 15-Oct-2015 | Communication on Progress | Active |
| 15-Oct-2014 | Astellas Annual Report 2014 | Active |
| 18-Oct-2013 | Communication on Progress | Active |
| 18-Oct-2012 | Astellas Annual Report 2012 | Active |